Elevance Health Inc
ELV424.550USD
-10.490-2.41%
Cierre 04/17, 16:00（ET）Cotizaciones retrasadas 15 min
96.58BCap. mercado
16.15P/E TTM
Información de Elevance Health Inc Compañía
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Información de la empresa
Código de la empresaELV
Nombre de la empresaElevance Health Inc
Fecha de salida a bolsaOct 30, 2001
Fundada en2001
Director ejecutivoMs. Gail K. Boudreaux
Número de empleados103158
Tipo de títulosOrdinary Share
Fin del año fiscalOct 30
Dirección220 Virginia Avenue
CiudadINDIANAPOLIS
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46204
Teléfono18003311476
Sitio Webhttps://www.elevancehealth.com/
Código de la empresaELV
Fecha de salida a bolsaOct 30, 2001
Fundada en2001
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
149.75K
+11.80%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Chairman of the Board
Independent Chairman of the Board
10.29K
--
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
8.74K
--
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.32K
--
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.19K
--
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.04K
--
Mr. Charles Morgan Kendrick, Jr.
Mr. Charles Morgan Kendrick, Jr.
Executive Vice President and President, Commercial and Specialty Health Benefits
Executive Vice President and President, Commercial and Specialty Health Benefits
--
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Ms. Felicia F. Norwood
Ms. Felicia F. Norwood
Executive Vice President and President, Government Health Benefits
Executive Vice President and President, Government Health Benefits
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
149.75K
+11.80%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Chairman of the Board
Independent Chairman of the Board
10.29K
--
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
8.74K
--
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.32K
--
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.19K
--
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Desglose de ingresos
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
No datos encontrados
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
Accionista
Hora de actualización: hace 13 horas
Hora de actualización: hace 13 horas
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.45%
BlackRock Institutional Trust Company, N.A.
5.20%
State Street Global Advisors (US)
4.72%
T. Rowe Price Associates, Inc.
4.52%
Wellington Management Company, LLP
2.81%
Other
73.30%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.45%
BlackRock Institutional Trust Company, N.A.
5.20%
State Street Global Advisors (US)
4.72%
T. Rowe Price Associates, Inc.
4.52%
Wellington Management Company, LLP
2.81%
Other
73.30%
Tipo
Accionista
Proporción
Investment Advisor
43.71%
Investment Advisor/Hedge Fund
40.97%
Pension Fund
2.64%
Hedge Fund
2.62%
Bank and Trust
2.51%
Research Firm
1.81%
Sovereign Wealth Fund
1.45%
Family Office
0.27%
Family Office
0.27%
Other
3.74%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
3022
212.89M
94.03%
-4.73M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
2023Q1
2729
219.91M
92.66%
-8.42M
2022Q4
2684
220.86M
92.46%
-8.53M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
21.38M
9.45%
+141.85K
+0.67%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
11.78M
5.2%
+200.94K
+1.74%
Dec 31, 2024
State Street Global Advisors (US)
10.68M
4.72%
-5.71K
-0.05%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.24M
4.52%
+459.21K
+4.70%
Dec 31, 2024
Wellington Management Company, LLP
6.36M
2.81%
+1.89M
+42.45%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.96M
2.19%
+115.97K
+2.39%
Dec 31, 2024
Sanders Capital, LLC
4.69M
2.07%
+76.90K
+1.67%
Dec 31, 2024
Capital International Investors
3.88M
1.71%
+35.58K
+0.93%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
3.23M
1.42%
+1.04M
+47.56%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
12.36%
Monarch Dividend Plus Index ETF
3.5%
First Eagle Global Equity ETF
3.41%
Brookstone Value Stock ETF
3.3%
GMO US Quality ETF
3.1%
Simplify Market Neutral Equity Long/Short ETF
3.07%
Eagle Capital Select Equity ETF
2.62%
NYLI Healthy Hearts ETF
2.6%
Invesco S&P 500 Enhanced Value ETF
2.26%
FT Cboe Vest Rising Dividend Achievers Target Inc
2.21%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción12.36%
Monarch Dividend Plus Index ETF
Proporción3.5%
First Eagle Global Equity ETF
Proporción3.41%
Brookstone Value Stock ETF
Proporción3.3%
GMO US Quality ETF
Proporción3.1%
Simplify Market Neutral Equity Long/Short ETF
Proporción3.07%
Eagle Capital Select Equity ETF
Proporción2.62%
NYLI Healthy Hearts ETF
Proporción2.6%
Invesco S&P 500 Enhanced Value ETF
Proporción2.26%
FT Cboe Vest Rising Dividend Achievers Target Inc
Proporción2.21%
Dividendos
Un total de
6.19B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
No datos encontrados
Fecha
Tipo
Relación
No datos encontrados